Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022 By: Harrow Health, Inc. via Business Wire July 27, 2022 at 07:00 AM EDT Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Tuesday, August 9, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 8466369): (telephonic replay through August 16, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through November 9, 2022) harrowinc.com About Harrow Health Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005305/en/Contacts Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022 By: Harrow Health, Inc. via Business Wire July 27, 2022 at 07:00 AM EDT Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Tuesday, August 9, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 8466369): (telephonic replay through August 16, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through November 9, 2022) harrowinc.com About Harrow Health Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005305/en/Contacts Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737
Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Tuesday, August 9, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 8466369): (telephonic replay through August 16, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through November 9, 2022) harrowinc.com About Harrow Health Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005305/en/